BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23092808)

  • 1. [FMEA applied to the radiotherapy patient care process].
    Meyrieux C; Garcia R; Pourel N; Mège A; Bodez V
    Cancer Radiother; 2012 Oct; 16(7):613-8. PubMed ID: 23092808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Systematic approach for dysfunctional analysis in radiotherapy].
    Reitz A; Levrat E; Pétin JF; Noël A; Aigle D; Peiffert D; Graff P
    Cancer Radiother; 2012 Dec; 16(8):667-73. PubMed ID: 23142180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk analysis by FMEA as an element of analytical validation.
    van Leeuwen JF; Nauta MJ; de Kaste D; Odekerken-Rombouts YM; Oldenhof MT; Vredenbregt MJ; Barends DM
    J Pharm Biomed Anal; 2009 Dec; 50(5):1085-7. PubMed ID: 19640668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of failure mode and effects analysis to intraoperative radiation therapy using mobile electron linear accelerators.
    Ciocca M; Cantone MC; Veronese I; Cattani F; Pedroli G; Molinelli S; Vitolo V; Orecchia R
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e305-11. PubMed ID: 21708432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of failure mode and effect analysis in a radiology department.
    Thornton E; Brook OR; Mendiratta-Lala M; Hallett DT; Kruskal JB
    Radiographics; 2011; 31(1):281-93. PubMed ID: 20980666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing FMEA and RCA efforts in health care.
    Latino RJ; Flood A
    J Healthc Risk Manag; 2004; 24(3):21-8. PubMed ID: 20196009
    [No Abstract]   [Full Text] [Related]  

  • 7. FMEA: a model for reducing medical errors.
    Chiozza ML; Ponzetti C
    Clin Chim Acta; 2009 Jun; 404(1):75-8. PubMed ID: 19298799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cartography and risk management in radiotherapy: A collaborative work of the department of radiotherapy and the department of quality and risk management at the Jean-Godinot Institute].
    Nguyen TD; Devie I; Heusghem M; Gaillot-Petit N; Loiseau M
    Cancer Radiother; 2010 Jan; 14(1):24-8. PubMed ID: 19969499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical risk analysis with failure mode and effect analysis (FMEA) model in a dialysis unit.
    Bonfant G; Belfanti P; Paternoster G; Gabrielli D; Gaiter AM; Manes M; Molino A; Pellu V; Ponzetti C; Farina M; Nebiolo PE
    J Nephrol; 2010; 23(1):111-8. PubMed ID: 20091494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Functional modeling for risk analysis in radiotherapy].
    Reitz A; Pétin JF; Levrat E; Noel A; Aigle D; Peiffert D; Graff P
    Cancer Radiother; 2012 Dec; 16(8):653-60. PubMed ID: 23182502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk analysis in radiation therapy: state of the art].
    Mazeron R; Aguini N; Deutsch É
    Cancer Radiother; 2013; 17(4):308-16, quiz 332. PubMed ID: 23787020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tools for developing a quality management program: proactive tools (process mapping, value stream mapping, fault tree analysis, and failure mode and effects analysis).
    Rath F
    Int J Radiat Oncol Biol Phys; 2008; 71(1 Suppl):S187-90. PubMed ID: 18406925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a systematic risk analysis method to improve safety in the production of paediatric parenteral nutrition solutions.
    Bonnabry P; Cingria L; Sadeghipour F; Ing H; Fonzo-Christe C; Pfister RE
    Qual Saf Health Care; 2005 Apr; 14(2):93-8. PubMed ID: 15805453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of failure mode and effect analysis in a radiation oncology setting: the Cancer Treatment Centers of America experience.
    Denny DS; Allen DK; Worthington N; Gupta D
    J Healthc Qual; 2014; 36(1):18-28. PubMed ID: 22364244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiology failure mode and effect analysis: what is it?
    Abujudeh HH; Kaewlai R
    Radiology; 2009 Aug; 252(2):544-50. PubMed ID: 19703888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure mode and effect analysis for delivery of lung stereotactic body radiation therapy.
    Perks JR; Stanic S; Stern RL; Henk B; Nelson MS; Harse RD; Mathai M; Purdy JA; Valicenti RK; Siefkin AD; Chen AM
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1324-9. PubMed ID: 22197236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consistency of FMEA used in the validation of analytical procedures.
    Oldenhof MT; van Leeuwen JF; Nauta MJ; de Kaste D; Odekerken-Rombouts YM; Vredenbregt MJ; Weda M; Barends DM
    J Pharm Biomed Anal; 2011 Feb; 54(3):592-5. PubMed ID: 20970277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure mode and effect analysis: an application in reducing risk in blood transfusion.
    Burgmeier J
    Jt Comm J Qual Improv; 2002 Jun; 28(6):331-9. PubMed ID: 12066625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Identifying and prioritising adverse episodes and failures related to patient safety in Pain Treatment Units].
    Pérez Lázaro JJ; Fernández Ruiz I; Tejedor Fernández M; Guerra de Hoyos JA; Jiménez Rodríguez M; de Pazzis Die de Ortega M; Insausti Valdivia J; Rodríguez López M; Romero Cotelo J; Gálvez Mateos R
    Rev Esp Anestesiol Reanim; 2012 Oct; 59(8):423-9. PubMed ID: 22742871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applying failure mode effects and criticality analysis in radiotherapy: lessons learned and perspectives of enhancement.
    Scorsetti M; Signori C; Lattuada P; Urso G; Bignardi M; Navarria P; Castiglioni S; Mancosu P; Trucco P
    Radiother Oncol; 2010 Mar; 94(3):367-74. PubMed ID: 20116118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.